ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

EAPI Euroapi SA

3.604
0.044 (1.24%)
28 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Euroapi SA EU:EAPI Euronext Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.044 1.24% 3.604 3.60 3.62 3.636 3.52 3.574 261,890 16:40:00

Availability of the 2023 Universal Registration Document, including the Annual Financial Report

05/04/2024 5:20pm

GlobeNewswire Inc.


Euroapi (EU:EAPI)
Historical Stock Chart


From Mar 2024 to May 2024

Click Here for more Euroapi Charts.
Availability of the 2023 Universal Registration Document, including the Annual Financial Report
 Press Release    

Paris – April 5, 2024 – EUROAPI announces the publication of its 2023 Universal Registration Document, filed with the French Autorité des marchés financiers (AMF) on April 5, 2024.

The 2023 Universal Registration Document includes in particular:

  • The annual financial report;
  • The Board of Directors’ corporate governance report;
  • The information about social, environmental, and societal responsibility (including the extra-financial performance declaration);
  • The statutory auditors reports, including the special report on the regulated agreements;
  • The disclosures relating to statutory auditors’ fees; and
  • The description of the share buy-back program.

This document is available on EUROAPI’s website: https://www.euroapi.com/en/investors/regulatory-information/financial-reports and on the AMF website (www.amf-france.org). The document is made available to the public under the conditions provided by the regulations in force.

About EUROAPIEUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the world. We are a leading player in active pharmaceutical ingredients with approximately 200 products in our portfolio, offering a large span of technologies while developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO) activities.

Taking action for health by enabling access to essential therapies inspires our 3,650 people every day. With strong research and development capabilities and six manufacturing sites, all located in Europe, EUROAPI ensures API manufacturing of the highest quality to supply customers in more than 80 countries. EUROAPI is listed on Euronext Paris; ISIN: FR0014008VX5; ticker: EAPI). Find out more at www.euroapi.com and follow us on LinkedIn.

Media Relations contact:Laurence BollackTel.: +33 (0)6 81 86 80 19mr@euroapi.com    Investor Relations contacts:Sophie Palliez-CapianTel.: +33 (0)6 87 89 33 51Sophie.palliez@euroapi.com Camile RicotierTel : +33 (0)6 43 29 93 79Camille.ricotier@euroapi.com

Attachment

  • EUROAPI - Press release - April 5, 2024

1 Year Euroapi Chart

1 Year Euroapi Chart

1 Month Euroapi Chart

1 Month Euroapi Chart

Your Recent History

Delayed Upgrade Clock